Deerfield Management Company »

Genedx Holdings Corp shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Genedx Holdings Corp (WGS) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Genedx Holdings Corp

Tip: Access up to 7 years of quarterly data

All positions including Genedx Holdings Corp held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genedx Holdings Corp by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 643k 2.75
2023-09-30 $4.6M 1.3M 3.64
2023-06-30 $7.5M 1.3M 5.96

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Genedx Holdings Corp

Casdin Capital
Corvex Management
Goldman Sachs Group
Blackstone Group
Vanguard Group
Deerfield Management Company
Gagnon Securities
Jacobs Levy Equity Management
Oracle Investment Management
Gagnon Advisors
Millennium Management
Decheng Capital
Tang Capital Management
Soleus Capital Management
Pathstone Holdings

View all funds holding Genedx Holdings Corp